A low “CD34+ tot” level in the graft (Figure 3A; p = 0.014) and a low CD34+ dose (cells/kg; Figure 3B; p = 0.015) were both associated with the occurrence of aGVHD in the AML patients. The gene discussed is CD34; the disease is acute myeloid leukemia.